MECOM and acute myeloid leukemia: However, no chimeric transcript has been isolated in most AML cases with atypical 3q26.2/MECOM-R; therefore, the underlying mechanism of dysregulation of MECOM in these cases very likely mimics cases with typical 3q26.2/MECOM-R, as mentioned above.